Search

everythinglearnresearchcommunity

for

Search:↓

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Different oral anticoagulants cause various non-bleeding side effects, so careful monitoring is needed.

The new compound may be a safer alternative to finasteride for prostate protection.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

4-octyl itaconate may prevent hearing loss caused by the drug cisplatin by activating certain cell protection pathways.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Both finasteride and drospirenone treatments improved symptoms and increased pregnancy rates in women with polycystic ovary syndrome.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.